Age-dependent clinical, molecular, and prognostic differences in patients with AML: a retrospective study
This study revealed that patients aged ≥50 years displayed more complex genetic aberration profiles and experienced significantly poorer prognoses compared to their younger counterparts. These findings provided novel insights for optimizing treatment strategies for middle-aged and elderly AML patients in the Chinese population.
Authors
- Hong Liu
- Yue Chen
- Yang Su
- Zhi Li
- Liang Yu
- Jingjing Ma
- Chunling Wang
- Tingting Ji
- Shandong Tao
- Qiuni Chen
- Yuye Shi
Institutions
- Xuzhou Medical College (CN)
- Second People’s Hospital of Huai’an (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Hematology
- Published
- 2026-01-27
- DOI
- https://doi.org/10.1080/16078454.2026.2622254
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00